Education And Debate
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: EntanglementBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7400.1189 (Published 29 May 2003) Cite this as: BMJ 2003;326:1189
- Editor's Choice Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.0-g
- Editorial Published: 23 February 2006; BMJ 332 doi:10.1136/bmj.332.7539.437
- Letter Published: 29 April 2004; BMJ 328 doi:10.1136/bmj.328.7447.1077
- Authors’ reply to RamachandranBMJ September 29, 2016, 354 i5255; DOI: https://doi.org/10.1136/bmj.i5255
- Two years of sunshine: has openness about payments reduced industry influence in healthcare?BMJ August 25, 2016, 354 i4608; DOI: https://doi.org/10.1136/bmj.i4608
- US device industry and FDA “colluded” on legislation to weaken regulatory oversightBMJ December 17, 2015, 351 h6820; DOI: https://doi.org/10.1136/bmj.h6820
- Punjab Medical Council investigates doctors for alleged payments from drug companiesBMJ October 27, 2015, 351 h5655; DOI: https://doi.org/10.1136/bmj.h5655
- Logging The BMJ’s “patient journey”BMJ August 17, 2015, 351 h4396; DOI: https://doi.org/10.1136/bmj.h4396
- Diaspora of clinical medicine: Exploring the rift between conventional and alternative health care
- Between the needy and the greedy: the quest for a just and fair ethics of clinical research
- Good prescribing: better systems and prescribers needed
- Guidelines in the United Kingdom and How They Are Used
- Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications
- Should the drug industry work with key opinion leaders? Yes
- General practitioners and pharmaceutical sales representatives: quality improvement research
- Physicians' intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry
- The schizophrenia drug-treatment paradox: pharmacological treatment based on best possible evidence may be hardest to practise in high-income countries
- Sources de partialite chez les auteurs de guides de pratique clinique
- Sources of bias for authors of clinical practice guidelines.
- Behavioural medicine: changing our behaviour.
- The Proliferation of Clinical Practice Guidelines: Professional Development or Medicine-by-Numbers?
- The role of the pharmaceutical industry in neurologic education
- The Truth About the Drug Companies: How they deceive us and what to do about it
- Minding the gap: can continuing medical education bridge the quality chasm?
- A glossary for evidence based public health
- E is for equivocal in EBM
- How to make journal clubs interesting
- Prognosis of entanglement could be serious
- No more free lunches